• Tech
• Gadgets
• Mobile
• Enterprise
• CrunchBase
• More
  • Beta Invites
  • Elevator Pitches
  • Gillmor Gang
  • Podcasts
  • TechCrunch50
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Aravis Ventures

edit

Aravis Ventures is a financial organisation which targets its investments in the fields of life sciences and renewable energy. Their investments are focused in Europe, Asia and North America.

Milestones

edit

• 
  Aravis Ventures invested in Evolva. (10/22/09)
  Posted 10/28/09 at 7:50am
• 
  Aravis Ventures invested in NovImmune. (5/12/09)
  Posted 6/17/09 at 1:31pm
• 
  Aravis Ventures invested in Ambrx. (4/1/09)
  Posted 4/13/09 at 1:07pm
• 
  Aravis Ventures invested in Synosia Therapeutics. (1/09)
  Posted 5/20/09 at 2:28pm
• 
  Aravis Ventures invested in S*Bio. (10/20/08)
  Posted 6/18/09 at 4:35pm

Investments

Videos

Sources

1. Evolva hauls in $28M to grease Arpida merger (fiercebiotech.com) [edit]
2. NovImmune, SA: Series C $54.8M (onbiovc.com) [edit]
3. Ambrx, Inc.: Series D $10M (onbiovc.com) [edit]
4. Synosia raises $29M for Phase II testing (fiercebiotech.com) [edit]
5. Capital Report Index [edit]